PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tumors elude anti-cancer drugs through 'fork reversal' repair, SLU scientists discover

Findings may allow lower doses of chemotherapy, limit toxic side effects

2013-08-06
(Press-News.org) ST. LOUIS -- In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors. The discovery points to opportunities to improve chemotherapeutic regimens based on topoisomerase I inhibitor treatment and limit their toxic side effects.

"Most cancer chemotherapeutics act by inhibiting DNA replication," Vindigni said. "The drugs aim to target highly proliferating cancer cells rather than normal cells, but unfortunately many also are toxic for normal cells."

Cells, both healthy and cancerous, reproduce by replicating their DNA. Anti-cancer drugs like topoisomerase I (TOP1) inhibitors work by disrupting DNA replication in cancer cells.

As a cell's double helix-shaped DNA strands split apart and begin to copy themselves, the long strands get wound up, like a rope that's been twisted too many times. The coils must be released or replication can't continue to move forward. Topoisomerase is an enzyme that temporarily cuts the rope of DNA, lets it untwist, and puts it back together again. If you block this process with a TOP1 inhibitor, the rope remains knotted and cell duplication stops.

Scientists' understanding of how TOP1 inhibitors work has, however, been incomplete. The working theory has been that TOP1 inhibitors leave a nick on one of the DNA strands by inhibiting the ability of the topoisomerase to seal the broken DNA. When the replication machinery collides with this nick, a double strand break occurs which stops the replication process. Double strand breaks are the worst kind of DNA lesions because both strands are compromised and require a complicate DNA repair pathway to be fixed.

In his recent findings, however, Vindigni and his team found that the cells are much "smarter" than they originally appeared.

Living up to their crafty reputation, cancer cells have a strategy to deal with this scenario. When TOP1 inhibition causes "replication stress" in the form of a nick on the DNA, the replication machinery pauses and reverses its course instead of colliding with the TOP1 induced DNA lesion. This mechanism of "replication fork reversal" gives time for the lesion to be repaired, so that replication can continue on again, preventing the hoped-for double strand break.

In fact, not only does the strand halt when it reaches the nick, but it senses the problem ahead of time, coming down the line. The replication structure does not operate blindly, but has advance notice of the injury, which gives it time to halt and repair the lesion before it reverses course and move into forward gear again.

"This is important because it is the first evidence that says that cancer cells' DNA replication machinery can react to drug treatment through fork reversal. Now we also uncovered the mechanism to restart the replication forks."

Vindigni's team also found that two important cellular proteins, PARP and RECQ1, control the fork reversal mechanism.

In particular, RECQ1, which is an enzyme that plays a key role in the maintenance of genome stability, appears to be responsible for restarting the reversed replication forks once the TOP1 induced lesion has been repaired. The reversed forks cannot restart without the help of RECQ1, suggesting it may be a promising target for a drug therapy.

Once they undercut the replication fork reversal process, researchers can return to the approach of encouraging a "fatal" double strand break for cancer cells by combing TOP1 inhibitors with novel inhibitors of the proteins that control the process of replication fork reversal and restart. In addition, inducing replication fork reversal by TOP1 inhibitor treatment and impeding reversed replication fork restart by RECQ1 inhibition should also stop DNA replication, thus allowing doctors to use lower TOP1 inhibitor doses, which, in turn, would mean fewer side effects.

What's next?

Researchers' next step is to determine if this mechanism holds true not just in response to TOP1 inhibitors, but also with other cancer drugs, a finding that would broaden this paper's significance even further.

Another important step will be to search for other factors that control the replication fork reversal process, findings which would offer additional opportunities to disrupt the process.

"TOP1 drugs are widely used in clinic for many types of cancer. However, they also are highly toxic," Vindigni said. "We discovered the mechanism that the cancer cells' replication machinery uses to respond to treatment with these drugs. We also discovered the factors that control this mechanism.

"We hope to combine new RECQ1 inhibitors with existing drugs to create more effective and specific therapies with fewer toxic side effects."

This research was funded by the Saint Louis University's President's Research Fund, the Saint Louis University Cancer Center, the National Institutes of Health, the Associazione Italiana per la Ricerca sul Cancro and Swiss National Science Foundation grants, among others.

TAKE AWAYS:

Anti-cancer drugs like topoisomerase I (TOP1) inhibitors work by disrupting DNA replication. Vindigni's research team found the first evidence that cancer cells' DNA replication machinery can react to drug treatment with a repair process called fork reversal, including a mechanism to restart the replication forks. The team described the mechanism of fork reversal and the factors that control it, PARP and RECQ1. Researchers hope to combine new RECQ1 inhibitors with existing drugs to create more effective and specific therapies with fewer toxic side effects.



INFORMATION:



Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious disease.



ELSE PRESS RELEASES FROM THIS DATE:

Team finds gene mutation that increases risk of schizophrenia, learning impairment

2013-08-06
A collaborative team of researchers including scientists from UCLA has uncovered evidence that a specific genetic alteration appears to contribute to disorders of brain development, including schizophrenia. They also found that schizophrenia shares a common biological pathway with Fragile X mental retardation syndrome, a disorder associated with both intellectual impairment and autism. A disruption of the gene known as TOP3B was associated with an increased risk of schizophrenia as well as impairment in intellectual function, the researchers said, and TOP3B's interaction ...

Smoke-free casinos reduce medical emergencies

2013-08-06
Commercial casinos throughout the country are often exempt from smoke-free workplace laws. Now a new study led by UC San Francisco has found that when smoking is banned in casinos, it results in considerably fewer emergency calls for ambulances. The study is the first to examine the health impact of smoking bans in casinos. The authors conclude that if smoke-free laws were to apply to casinos as well as other businesses, it would prevent many medical emergencies and reduce public health costs. "Our study suggests that exempting casinos from smoke-free laws means ...

Cilostazo: A new treatment against cognitive dysfunction in chronic cerebral ischemia

2013-08-06
Hypoxia-inducible factor-1 and its specific target gene heme oxygenase-1 are involved in acute cerebral ischemia. However, very few studies have examined in detail the changes in the hypoxia-inducible factor-1/heme oxygenase-1 signaling pathway in chronic cerebral ischemia. Prof. Zhongxin Xu and team from China-Japan Friendship Hospital, Jilin University clarified that the hypoxia-inducible factor-1/heme oxygenase-1 signaling pathway is activated following chronic cerebral ischemia and involved in the development of cognitive impairment induced by chronic cerebral ischemia. ...

A real-time system that provides detection and detection and identification of epilepsy

2013-08-06
The automatic detection and identification of electroencephalogram waves play an important role in the prediction, diagnosis and treatment of epileptic seizures. Unfortunately, in previous experiments, training data and test data from electroencephalogram signals are often derived from the same cases, which may affect the clinical applicability of the classifiers. Zhen Zhang and colleagues from Zhongshan School of Medicine, Sun Yat-sen University combined a nonlinear dynamics index–approximate entropy with a support vector machine that has strong generalization ability ...

Is decimeter wave therapy a better choice for sciatic nerve regeneration?

2013-08-06
Drug treatment, electric stimulation and decimeter wave therapy have been shown to promote the repair and regeneration of the peripheral nerves at the injured site. Feng Zhao and colleagues from Hebei Medical University investigated the effects of intraoperative electric stimulation and decimeter waves on sciatic nerve regeneration in a Mackinnon's model of rat sciatic nerve compression. These results, published in the Neural Regeneration Research (Vol. 8, No. 21, 2013) verified that intraoperative electric stimulation and decimeter wave therapy contributed to the regeneration ...

Weight loss surgery alters fatty liver disease genes

2013-08-06
Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also reverse the symptoms of fatty liver disease. The findings, which are to be published online on August 6 in the Cell Press journal Cell Metabolism, are derived from research on liver samples in normal and obese patients—some with fatty liver disease and some without fatty liver disease. The results provide another example of the DNA-altering effects ...

Women in large urban areas at higher risk of postpartum depression

2013-08-06
Women living in large urban centres in Canada with more than 500 000 inhabitants were at higher risk of postpartum depression than women in other areas, according to a study in CMAJ (Canadian Medical Association Journal). Postpartum depression is a serious health concern for women and their children around the world. Major risk factors include lack of social support and a history of depression. In Canada, about 20% of people live in rural or remote regions, 35% live in the large urban areas of Montréal, Toronto and Vancouver, with the remaining 45% in semirural or semiurban ...

New trap and lure captures bed bugs more effectively

2013-08-06
A new pitfall trap designed to capture bed bugs is more effective than those currently on the market, according to the authors of an article appearing in the next issue of the Journal of Economic Entomology. The authors also found that traps baited with an experimental chemical lure mixture caught 2.2 times as many bed bugs as traps without the lure. Their findings suggest that an effective and affordable bed bug monitor can be made incorporating the new pitfall trap design, a chemical lure, and a sugar-and-yeast mixture to produce carbon dioxide, which is also known to ...

D-dimer plasma level: A reliable marker for venous thromboembolism after craniotomy

2013-08-06
Charlottesville, VA (August 6, 2013). The D-dimer test is often used to rule out the presence of venous thromboembolism; however, the test has been considered unreliable in postoperative patients because D-dimer levels may rise after surgery. Researchers from the Department of Neurosurgery at the University of Halle in Germany hypothesized that this rise might be systematic and predictable, in which case a feasible postoperative threshold of D-dimer indicating venous thromboembolism could be determined. The results of this study show that the researchers were able to determine ...

Emotional behavior of adults could be triggered in the womb

2013-08-06
Adults could be at greater risk of becoming anxious and vulnerable to poor mental health if they were deprived of certain hormones while developing in the womb according to new research by scientists at Cardiff and Cambridge universities. New research in mice has revealed the role of the placenta in long-term programming of emotional behaviour and the first time scientists have linked changes in adult behaviour to alterations in placental function. Insulin-like growth factor-2 has been shown to play a major role in foetal and placental development in mammals, and changes ...

LAST 30 PRESS RELEASES:

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day

Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds

Bronze and Iron Age cultures in the Middle East were committed to wine production

Indian adolescents are mostly starting their periods at an earlier age than 25 years ago

Temporary medical centers in Gaza known as "Medical Points" (MPs) treat an average of 117 people daily with only about 7 staff per MP

Rates of alcohol-induced deaths among the general population nearly doubled from 1999 to 2024

PLOS One study: In adolescent lab animals exposed to cocaine, High-Intensity Interval Training boosts aversion to the drug

Scientists identify four ways our bodies respond to COVID-19 vaccines

Stronger together: A new fusion protein boosts cancer immunotherapy

Hidden brain waves as triggers for post-seizure wandering

[Press-News.org] Tumors elude anti-cancer drugs through 'fork reversal' repair, SLU scientists discover
Findings may allow lower doses of chemotherapy, limit toxic side effects